Bolt Biotherapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Great. Good afternoon, everybody, and thanks for joining us for the next session. I am Matthew Harrison, one of the biopharma analysts here at Morgan Stanley. Very pleased to have Bolt Bio with us for the next session. Before we get started, I just need to read a quick disclosure statement. Please note that all important disclosures including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/research disclosures. And to kick us off, I'm going to turn it over to Randy Schatzman, who is the CEO of Bolt and let him make some opening comments and then we can jump right into it.
Thanks, Matthew, and thanks to the team at Morgan Stanley for including us in what's been a really constructive meeting for us today. I'm joined by Willie Quinn, who is our Chief Financial Officer. And obviously we'll both be answering your questions as you take us through after my opening remarks here.
So just for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
